AbbVie Inc.
Financial Performance
AbbVie Revenue & Financials
Revenue
$61.2B (FY2025)
Market Cap
$465.8B
Net Income
$4.2B
Employees
57,000
What is AbbVie's revenue?
AbbVie had $61.2B in revenue for fiscal year 2025, up 8.6% from 2024. Net income was $4.2B.
- Latest revenue
- $61.2B (FY2025)
- Year-over-year
- +8.6%
- Growth rate (CAGR)
- 10.1% over 9 years
- Peak revenue
- $61.2B (FY2025)
- Years of data
- 10
- Employees
- 57,000
- What is AbbVie's operating income?
- AbbVie reported operating income of $15.1B for fiscal year 2025. sec.gov
- How much profit does AbbVie make?
- AbbVie reported net income of $4.2B for fiscal year 2025. data.sec.gov
- How many employees does AbbVie have?
- AbbVie has about 57,000 employees.
Financial Analysis
AbbVie reported $61.160 billion of FY2025 net revenue and $4.226 billion of net income. Skyrizi and Rinvoq generated $25.866 billion combined, while Humira declined to $4.540 billion after U.S. biosimilar entry. The 2020 Allergan acquisition added neuroscience and aesthetics revenue, and the 2024 ImmunoGen and Cerevel acquisitions added oncology and neuroscience assets. AbbVie is a dominant biopharmaceutical company, sustaining a massive market valuation often exceeding $250 billion, heavily driven by its blockbuster immunology and aesthetics portfolios.
Revenue Trend Analysis
YoY Change
+8.6%
9-Year CAGR
+10.1%
Peak Year
2025
Trend
Consistent Growth
AbbVie Inc. has 10 full fiscal year figures on this page, compounding at +10.1% annually over 9 years. The most recent year saw a 8.6% increase versus the prior year. Annual revenue peaked in fiscal year 2025 at $61.2B. Of 9 comparable year-over-year steps, 8 showed growth and 1 showed a decline.
Annual revenue history
| Fiscal Year | Revenue | Operating Income | Net Income | YoY Change | Source |
|---|---|---|---|---|---|
| FY2025 | $61.2B | $15.1Bfiling | $4.2B | +8.6% | SEC EDGAR company facts for AbbVie Inc. FY2025 net revenue and net income; also reported in AbbVie's February 2026 results and Form 10-K. |
| FY2024 | $56.3B | $9.1Bfiling | $4.3B | +3.7% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2024 net revenue and net income as reported in AbbVie SEC filings. |
| FY2023 | $54.3B | $12.8Bfiling | $4.9B | -6.4% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2023 net revenue and net income as reported in AbbVie SEC filings. |
| FY2022 | $58.1B | $18.1Bfiling | $11.8B | +3.3% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2022 net revenue and net income as reported in AbbVie SEC filings. |
| FY2021 | $56.2B | $17.9Bfiling | $11.5B | +22.7% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2021 net revenue and net income as reported in AbbVie SEC filings. |
| FY2020 | $45.8B | $11.4Bfiling | $4.6B | +37.7% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2020 net revenue and net income as reported in AbbVie SEC filings. |
| FY2019 | $33.3B | $13Bfiling | $7.9B | +1.6% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2019 net revenue and net income as reported in AbbVie SEC filings. |
| FY2018 | $32.8B | $6.4Bfiling | $5.7B | +16.1% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2018 net revenue and net income as reported in AbbVie SEC filings. |
| FY2017 | $28.2B | $9.5Bfiling | $5.3B | +10.1% | SEC EDGAR company facts for AbbVie Inc. Fiscal 2017 net revenue and net income as reported in AbbVie SEC filings. |
| FY2016 | $25.6B | $9.3Bfiling | $6B | — | SEC EDGAR company facts for AbbVie Inc. Fiscal 2016 net revenue and net income as reported in AbbVie SEC filings. |
Click any row to see year details.
AbbVie Inc. balance sheet and cash flow
Balance-sheet figures are as of each fiscal year end; cash-flow figures cover the fiscal year. Taken from the company's annual report on Form 10-K, linked on each row. Free cash flow here is operating cash flow less capital expenditures, calculated by CorpDigest.
| Fiscal Year | Operating cash flow | Capital expenditures | Total assets | Shareholders' equity | Free cash flow | Source |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $19B | $1.2B | $134B | -$3.3B | $17.8B | Form 10-K |
| FY2024ended Dec 31, 2024 | $18.8B | $974M | $135.2B | $3.3B | $17.8B | Form 10-K |
| FY2023ended Dec 31, 2023 | $22.8B | $777M | $134.7B | $10.4B | $22.1B | Form 10-K |
| FY2022ended Dec 31, 2022 | $24.9B | $695M | $138.8B | $17.3B | $24.2B | Form 10-K |
| FY2021ended Dec 31, 2021 | $22.8B | $787M | $146.5B | $15.4B | $22B | Form 10-K |
| FY2020ended Dec 31, 2020 | $17.6B | $798M | $150.6B | $13.1B | $16.8B | Form 10-K |
| FY2019ended Dec 31, 2019 | $13.3B | $552M | $89.1B | -$8.2B | $12.8B | Form 10-K |
| FY2018ended Dec 31, 2018 | $13.4B | $638M | $59.4B | -$8.4B | $12.8B | Form 10-K |
| FY2017ended Dec 31, 2017 | $10B | $529M | $70.8B | $5.1B | $9.4B | Form 10-K |
| FY2016ended Dec 31, 2016 | — | $479M | $66.1B | $4.6B | — | Form 10-K |
Keep researching AbbVie
AbbVie Revenue and Financial FAQ
What was AbbVie's FY2025 revenue?
AbbVie reported $61.160 billion of FY2025 net revenue, up 8.6 percent on a reported basis.
What was AbbVie's FY2025 net income?
AbbVie reported $4.226 billion of FY2025 net income.
How much revenue did Skyrizi and Rinvoq generate in FY2025?
Skyrizi generated $17.562 billion and Rinvoq generated $8.304 billion, for $25.866 billion combined.
How much did AbbVie spend on R&D in FY2025?
AbbVie reported $9.096 billion of research and development expense and $5.016 billion of acquired IPR&D and milestone expense.
Is AbbVie a good dividend stock?
AbbVie is highly regarded by investors for its strong, consistently growing dividend, backed by massive free cash flow from its specialty drug portfolio.
Cite or embed this data
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "AbbVie Revenue & Financials." CorpDigest, https://corpdigest.com/company/abbvie/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>AbbVie reported $61.2B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/abbvie/financials" target="_blank" rel="noopener">CorpDigest — AbbVie financials</a></div>Related Financial Audits
Compare revenue, net income, and market cap scale
Explore AbbVie
Core profile pages, founders and related research hubs for this company.